Edition:
United States

Bio Path Holdings Inc (BPTH.OQ)

BPTH.OQ on NASDAQ Stock Exchange Capital Market

1.58USD
16 Feb 2018
Change (% chg)

$-0.02 (-1.25%)
Prev Close
$1.60
Open
$1.59
Day's High
$1.64
Day's Low
$1.53
Volume
17,072
Avg. Vol
17,403
52-wk High
$10.10
52-wk Low
$1.53

Chart for

About

Bio-Path Holdings, Inc. is a clinical and preclinical stage oncology focused antisense drug development company. The Company utilizes a technology that achieves systemic delivery for target specific protein inhibition for any gene product that is over-expressed in disease. Its drug delivery and antisense technology, DNAbilize,... (more)

Overall

Beta: 3.16
Market Cap(Mil.): $179.16
Shares Outstanding(Mil.): 113.39
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 178.11 17.27
EPS (TTM): -- -- --
ROI: -- -1.15 35.43
ROE: -- -20.84 17.10

BRIEF-Bio Path Holdings Says Board Increased Its Size From Four Members To Five Members

* BIO PATH HOLDINGS INC SAYS ON FEB 1, 2018, BOARD OF CO, INCREASED ITS SIZE FROM FOUR MEMBERS TO FIVE MEMBERS - SEC FILING Source text: [http://bit.ly/2GQ9Xup] Further company coverage:

Feb 05 2018

BRIEF-Bio Path Holdings Provides Clinical Update And 2018 Business Outlook

* BIO-PATH HOLDINGS PROVIDES CLINICAL UPDATE AND 2018 BUSINESS OUTLOOK

Dec 29 2017

BRIEF-Bio-Path Holdings Q3 loss per share $0.02

* Bio-Path Holdings reports third quarter 2017 financial results

Nov 09 2017

BRIEF-Bio-Path Holdings announces $4 mln registered direct offering

* Bio-Path Holdings, Inc. Announces $4 million registered direct offering

Nov 03 2017

Competitors

Earnings vs. Estimates